Thanks, Mr. Williamson.
Thank you, Mr. Fortin. I'm delighted you're here today. That was a great overview of what DRDC does.
I'm interested in some of the specific research you do on PTSD, in particular in the Toronto area. Some of that research has to do with quantifying salivary hormones; it has to do with melatonin devices. It's developing a device that is able to monitor the hormones and the endocrines in soldiers and identify those who, because of hormonal imbalances, would be most susceptible to PTSD prior to going into combat. It would be able to determine those sorts of balances between—and I'm not a scientist—the hypothalamic-pituitary-adrenal axis in the brain that is able to regulate the production of that hormone, which would then mitigate the effects of PTSD. Then we would be able to treat these soldiers before they developed these acute symptoms.
As well, there's also research going on in melatonin rhythms, including with sleep issues, on which we're going to hear from Dr. Moldofsky later.
Are you, or maybe Dr. Tremblay, able to comment on any of that?